Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 26 of the 26 references it cites were found in a registry or an index.

Rapid assessment of avoidable blindness-based healthcare costs of diabetic retinopathy in Hungary and its projection for the year 2045

Abstract

Background/aims: The purpose of this study was to estimate the total healthcare cost associated with diabetic retinopathy (DR) in the population aged 18 years and older in Hungary, and its projection for the year 2045. Methods: A cost model was developed based on the standardised rapid assessment of avoidable blindness with the diabetic retinopathy module (RAAB+DRM) methodology and recently reported prevalent-based cost of illness model. Projection for 2045 was made based on the estimation for increasing diabetes mellitus (DM) prevalence of the International Diabetes Federation. Costs were analysed from the perspective of the healthcare system and the patients. Our DR cost model was constructed according to the Scottish DR grading scale and based on the DR severity stadium. Results: The total DR-associated healthcare cost was US$145.8 million in 2016 and will increase to US$169.0 million by 2045. The two major cost drivers were intravitreal antivascular endothelial growth factor injections and vitrectomies in this study (US$126.4 million in 2016 and US$146.5 million in 2045); they amounted to 86.7% of the total treatment cost of DR. The DR-related cost per patient was US$180.5 in Hungary. Conclusions: The cost per patient for treating DR was lower in Hungary than in other countries. Due to the increasing socioeconomic burden of proliferative DR and diabetes-related blindness, it would be important to invest in DR screening, prevention and early treatment. Our new RAAB-based cost of DR model may facilitate comparisons of DR treatment costs across countries.

Overview

Integrity signals

Registry

Crossref · 10.1136/bjophthalmol-2020-316337

Cites

26 of 26 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

8 more claims about this paper

Create a free account to see every claim other papers make about this one.

See all claims — free account

Citations

Cites

Show all 26 references

Research works printed but not linked: 3

  1. Németh, 2011, Burden of disease of blindness among the elderly in Hungary, Lege Artis Med, 21, 641
  2. Németh, 2005, Causes of blindness in Hungary between 1996 and 2000, Szemészet, 142, 126
  3. Németh, 2019, Operating telemedicine ophthalmic screening programs and their possibilities in Hungary, Interdiszciplináris Magyar Egészségügy, 18, 46

Cited by

See all 12

Metadata

Authors
Tóth, G., Limburg, H., Szabó, D., Sándor, G. L., Nagy, Z. Z., & Németh, J.
Affiliations
Semmelweis University (HU)
Corresponding author
Tóth, Gábor
Venue
British Journal of Ophthalmology
Publisher
BMJ
Published
2020-08-11
Volume
105
Issue
8
Pages
1116-1120
ISSN
  • 0007-1161 (ISSN-L)
  • 1468-2079
OpenAlex
W3048513703
Cited by
11
References
26
Citations by year
2026: 1 · 2025: 1 · 2024: 1 · 2023: 2 · 2022: 4 · 2021: 2
FWCI
1.57
Type
journal article
Language
en
Open access
closed
Locations
  • British Journal of Ophthalmology (publishedVersion)
  • PubMed (publishedVersion)
Funders
Semmelweis Egyetem (EFOP-3.6.3-VEKOP-16-2017-00009)
Topics
  • Health Sciences › Medicine › Ophthalmology › Retinal Diseases and Treatments
  • Health Sciences › Medicine › Ophthalmology › Ophthalmology and Visual Impairment Studies
  • Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Retinal Imaging and Analysis
Keywords
diabetic retinopathy, health care costs, economic burden, avoidable blindness, intravitreal anti-VEGF injection, vitrectomy, proliferative diabetic retinopathy, diabetes prevalence, cost per patient
MeSH terms
Aged, Blindness, Diabetic Retinopathy, Female, Fluorescein Angiography, Health Surveys, Humans, Hungary, Male, Middle Aged, Ultrasonography, Health Care Costs, Laser Coagulation, Cost of Illness, Models, Economic, Angiogenesis Inhibitors, Tomography, Optical Coherence

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Rapid assessment of avoidable blindness-based healthcare costs of diabetic retinopathy in Hungary and its projection for the year 2045. https://app.cochat.ai/papers/10.1136/bjophthalmol-2020-316337
The paper
Tóth, G., Limburg, H., Szabó, D., Sándor, G. L., Nagy, Z. Z., & Németh, J. (2021). Rapid assessment of avoidable blindness-based healthcare costs of diabetic retinopathy in Hungary and its projection for the year 2045. British Journal of Ophthalmology. https://doi.org/10.1136/bjophthalmol-2020-316337

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.